221 related articles for article (PubMed ID: 34440435)
1. Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.
Huang CH; Yang CM; Yang CH; Hou YC; Chen TC
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440435
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.
Georgiou M; Robson AG; Fujinami K; de Guimarães TAC; Fujinami-Yokokawa Y; Daich Varela M; Pontikos N; Kalitzeos A; Mahroo OA; Webster AR; Michaelides M
Prog Retin Eye Res; 2024 May; 100():101244. PubMed ID: 38278208
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity Reclasssification of
Motta FL; Martin RP; Porto FBO; Wohler ES; Resende RG; Gomes CP; Pesquero JB; Sallum JMF
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31878136
[TBL] [Abstract][Full Text] [Related]
4. A novel recessive GUCY2D mutation causing cone-rod dystrophy and not Leber's congenital amaurosis.
Ugur Iseri SA; Durlu YK; Tolun A
Eur J Hum Genet; 2010 Oct; 18(10):1121-6. PubMed ID: 20517349
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of gene therapy on Leber's congenital amaurosis.
Bainbridge JW; Mehat MS; Sundaram V; Robbie SJ; Barker SE; Ripamonti C; Georgiadis A; Mowat FM; Beattie SG; Gardner PJ; Feathers KL; Luong VA; Yzer S; Balaggan K; Viswanathan A; de Ravel TJ; Casteels I; Holder GE; Tyler N; Fitzke FW; Weleber RG; Nardini M; Moore AT; Thompson DA; Petersen-Jones SM; Michaelides M; van den Born LI; Stockman A; Smith AJ; Rubin G; Ali RR
N Engl J Med; 2015 May; 372(20):1887-97. PubMed ID: 25938638
[TBL] [Abstract][Full Text] [Related]
6. Let There Be Light: Gene and Cell Therapy for Blindness.
Dalkara D; Goureau O; Marazova K; Sahel JA
Hum Gene Ther; 2016 Feb; 27(2):134-47. PubMed ID: 26751519
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel prediction model based on protein structure for identifying RPE65-associated inherited retinal disease (IRDs) of missense variants.
Wu J; Sun Z; Zhang DW; Liu HL; Li T; Zhang S; Wu J
PeerJ; 2023; 11():e15702. PubMed ID: 37547722
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials.
Jin Y; Li S; Jiang Z; Sun L; Huang L; Zhang T; Liu X; Ding X
Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):11. PubMed ID: 38466290
[TBL] [Abstract][Full Text] [Related]
9. Progression of phenotype in Leber's congenital amaurosis with a mutation at the LCA5 locus.
Mohamed MD; Topping NC; Jafri H; Raashed Y; McKibbin MA; Inglehearn CF
Br J Ophthalmol; 2003 Apr; 87(4):473-5. PubMed ID: 12642313
[TBL] [Abstract][Full Text] [Related]
10. Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence.
Kolesnikova M; Lima de Carvalho JR; Parmann R; Kim AH; Mahajan VB; Tsang SH; Sparrow JR
Mol Genet Genomic Med; 2022 Nov; 10(11):e2038. PubMed ID: 36225124
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic studies for a cohort of patients with Leber congenital amaurosis.
Zhou Y; Huang L; Xie Y; Liu W; Zhang S; Liu L; Lin P; Li N
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38662103
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy: perspectives from young adults with Leber's congenital amaurosis.
Napier MP; Selvan K; Hayeems RZ; Shuman C; Chitayat D; Sutherland JE; Day MA; Héon E
Eye (Lond); 2022 Nov; 36(11):2088-2093. PubMed ID: 34531550
[TBL] [Abstract][Full Text] [Related]
13. Generation of two induced pluripotent stem cell lines (LVPEIi004-A and LVPEIi005-A) from probands with Leber Congenital Amaurosis 2 (LCA2) and harboring mutations in RPE65.
Maddileti S; Mahato S; Agrawal T; Pravin Dave V; Naik M; Javed Ali M; Kannabiran C; Jalali S; Jayandharan GR; Mariappan I
Stem Cell Res; 2024 Jun; 77():103413. PubMed ID: 38631180
[TBL] [Abstract][Full Text] [Related]
14. RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec.
Stingl K; Priglinger C; Herrmann P
Klin Monbl Augenheilkd; 2024 Mar; 241(3):259-265. PubMed ID: 38508214
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Findings, Pathogenic Variants, and Gene Therapy Qualifications Found in a Leber Congenital Amaurosis Phenotypic Spectrum Patient Cohort.
Sather R; Ihinger J; Simmons M; Lobo GP; Montezuma SR
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279252
[TBL] [Abstract][Full Text] [Related]
16. In silico Mapping of Protein Unfolding Mutations for Inherited Disease.
McCafferty CL; Sergeev YV
Sci Rep; 2016 Dec; 6():37298. PubMed ID: 27905547
[TBL] [Abstract][Full Text] [Related]
17. LEBER CONGENITAL AMAUROSIS DUE TO CEP290 MUTATIONS-SEVERE VISION IMPAIRMENT WITH A HIGH UNMET MEDICAL NEED: A Review.
Leroy BP; Birch DG; Duncan JL; Lam BL; Koenekoop RK; Porto FBO; Russell SR; Girach A
Retina; 2021 May; 41(5):898-907. PubMed ID: 33595255
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Follow-Up of a Family with Retinal Dystrophy Caused by RPE65 Mutation.
Jánossy Á; Vizvári E; Lőrincz M; Pál S; Nagy D; Benedek G; Tóth-Molnár E; Janáky M
Case Rep Ophthalmol; 2023; 14(1):454-461. PubMed ID: 37901629
[TBL] [Abstract][Full Text] [Related]
19. [RPE65-retinal Dystrophies: From the Spectrum of the Clinical Picture to Gene Therapy].
Stingl K; Priglinger C
Klin Monbl Augenheilkd; 2024 Mar; 241(3):257-258. PubMed ID: 38508213
[No Abstract] [Full Text] [Related]
20. Screening for Autism Spectrum Disorder in Children and Adolescents With Leber's Congenital Amaurosis.
Sallum JMF; Pellissari MC; Carreiro LR; de Vasconcellos CFC
Am J Ophthalmol; 2024 May; 265():257-274. PubMed ID: 38777102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]